These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 9706063)
1. Single-dose pharmacokinetics of rifapentine in elderly men. Keung AC; Eller MG; Weir SJ Pharm Res; 1998 Aug; 15(8):1286-91. PubMed ID: 9706063 [TBL] [Abstract][Full Text] [Related]
2. Single-dose pharmacokinetics of rifapentine in women. Keung AC; Eller MG; Weir SJ J Pharmacokinet Biopharm; 1998 Feb; 26(1):75-85. PubMed ID: 9773393 [TBL] [Abstract][Full Text] [Related]
3. Single and multiple dose pharmacokinetics of rifapentine in man: part II. Keung A; Eller MG; McKenzie KA; Weir SJ Int J Tuberc Lung Dis; 1999 May; 3(5):437-44. PubMed ID: 10331734 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of rifapentine in subjects seropositive for the human immunodeficiency virus: a phase I study. Keung AC; Owens RC; Eller MG; Weir SJ; Nicolau DP; Nightingale CH Antimicrob Agents Chemother; 1999 May; 43(5):1230-3. PubMed ID: 10223941 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of rifapentine in patients with varying degrees of hepatic dysfunction. Keung AC; Eller MG; Weir SJ J Clin Pharmacol; 1998 Jun; 38(6):517-24. PubMed ID: 9650541 [TBL] [Abstract][Full Text] [Related]
8. Disposition and metabolism of 14C-rifapentine in healthy volunteers. Reith K; Keung A; Toren PC; Cheng L; Eller MG; Weir SJ Drug Metab Dispos; 1998 Aug; 26(8):732-8. PubMed ID: 9698286 [TBL] [Abstract][Full Text] [Related]
9. Enzyme induction observed in healthy volunteers after repeated administration of rifapentine and its lack of effect on steady-state rifapentine pharmacokinetics: part I. Keung A; Reith K; Eller MG; McKenzie KA; Cheng L; Weir SJ Int J Tuberc Lung Dis; 1999 May; 3(5):426-36. PubMed ID: 10331733 [TBL] [Abstract][Full Text] [Related]
10. Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers. Dooley KE; Savic RM; Park JG; Cramer Y; Hafner R; Hogg E; Janik J; Marzinke MA; Patterson K; Benson CA; Hovind L; Dorman SE; Haas DW; Antimicrob Agents Chemother; 2015; 59(6):3399-405. PubMed ID: 25824215 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy. Weiner M; Bock N; Peloquin CA; Burman WJ; Khan A; Vernon A; Zhao Z; Weis S; Sterling TR; Hayden K; Goldberg S; Am J Respir Crit Care Med; 2004 Jun; 169(11):1191-7. PubMed ID: 14962821 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the pharmacokinetic interaction between repeated doses of rifapentine or rifampin and a single dose of bedaquiline in healthy adult subjects. Winter H; Egizi E; Murray S; Erondu N; Ginsberg A; Rouse DJ; Severynse-Stevens D; Pauli E Antimicrob Agents Chemother; 2015 Feb; 59(2):1219-24. PubMed ID: 25512422 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers. Weiner M; Egelund EF; Engle M; Kiser M; Prihoda TJ; Gelfond JA; Mac Kenzie W; Peloquin CA J Antimicrob Chemother; 2014 Apr; 69(4):1079-85. PubMed ID: 24343893 [TBL] [Abstract][Full Text] [Related]
14. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys. Emary WB; Toren PC; Mathews B; Huh K Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285 [TBL] [Abstract][Full Text] [Related]
16. Physiologically Based Pharmacokinetic Model of Rifapentine and 25-Desacetyl Rifapentine Disposition in Humans. Zurlinden TJ; Eppers GJ; Reisfeld B Antimicrob Agents Chemother; 2016 Aug; 60(8):4860-8. PubMed ID: 27270284 [TBL] [Abstract][Full Text] [Related]
17. Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drug. Svensson EM; Murray S; Karlsson MO; Dooley KE J Antimicrob Chemother; 2015 Apr; 70(4):1106-14. PubMed ID: 25535219 [TBL] [Abstract][Full Text] [Related]
18. Single-dose intrapulmonary pharmacokinetics of rifapentine in normal subjects. Conte JE; Golden JA; McQuitty M; Kipps J; Lin ET; Zurlinden E Antimicrob Agents Chemother; 2000 Apr; 44(4):985-90. PubMed ID: 10722501 [TBL] [Abstract][Full Text] [Related]
19. The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis. Sirgel FA; Fourie PB; Donald PR; Padayatchi N; Rustomjee R; Levin J; Roscigno G; Norman J; McIlleron H; Mitchison DA Am J Respir Crit Care Med; 2005 Jul; 172(1):128-35. PubMed ID: 15805182 [TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: nonlinearities in clearance and bioavailability. Savic RM; Lu Y; Bliven-Sizemore E; Weiner M; Nuermberger E; Burman W; Dorman SE; Dooley KE Antimicrob Agents Chemother; 2014 Jun; 58(6):3035-42. PubMed ID: 24614383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]